Company: PACB
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001299130-25-000102
Chunk: 159

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 159
---
ITEM 1.  FINANCIAL STATEMENTS

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)

(In thousands, except par value)March 31,2025December 31,2024AssetsCurrent assets Cash and cash equivalents $58,507 $55,370 Investments 284,603 334,561 Accounts receivable, net31,645 27,524 Inventory, net54,007 58,755 Prepaid expenses and other current assets 15,471 18,781 Short-term restricted cash690 690 Total current assets 444,923 495,681 Property and equipment, net 24,794 30,505 Operating lease right-of-use assets, net 44,408 16,091 Long-term restricted cash1,532 1,532 Intangible assets, net18,182 389,572 Goodwill317,761 317,761 Other long-term assets 9,189 9,305 Total assets $860,789 $1,260,447 Liabilities and Stockholders’ Equity Current liabilitiesAccounts payable $14,037 $16,590 Accrued expenses 29,337 22,595 Deferred revenue, current 15,241 13,864 Operating lease liabilities, current2,417 10,026 Other liabilities, current 5,570 3,224 Total current liabilities 66,602 66,299 Deferred revenue, non-current 5,855 5,900 Contingent consideration liability, non-current— 18,700 Operating lease liabilities, non-current 50,480 14,914 Convertible senior notes, net, non-current646,214 647,494 Other liabilities, non-current — 546 Total liabilities 769,151 753,853 Commitments and contingencies Stockholders’ equityPreferred stock, $0.001 par value:Authorized 50,000 shares; No shares issued or outstanding — — Common stock, $0.001 par value:Authorized 1,000,000 shares; issued and outstanding 300,041 and 294,418 shares at March 31, 2025 and December 31, 2024, respectively 300 294 Additional paid-in capital 2,665,958 2,654,804 Accum